Exertional heat stroke, rhabdomyolysis and susceptibility to malignant hyperthermia

Internal Medicine Journal

Volumn 43, Issue 9, 2013, Pages 1035-1038

  Thomas, J ^a   Crowhurst, T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Genetic testing; Heat stroke; Malignant hyperthermia; Pharmacogenetics; Rhabdomyolysis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CAFFEINE; CALCIUM; CREATINE KINASE; CREATININE; DANTROLENE; GAMMA GLUTAMYLTRANSFERASE; HALOTHANE; IBUPROFEN; LACTATE DEHYDROGENASE; RYANODINE RECEPTOR 1;

ACUTE KIDNEY FAILURE; AEROBIC METABOLISM; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALGESIA; ARTICLE; AUSTRALIA AND NEW ZEALAND; AUTOSOMAL DOMINANT INHERITANCE; CALCIUM METABOLISM; CALCIUM TRANSPORT; CARNITINE DEFICIENCY; CHROMOSOME 19Q; CONGESTIVE HEART FAILURE; COOLING; DISEASE PREDISPOSITION; DISSEMINATED INTRAVASCULAR CLOTTING; EMERGENCY WARD; ENVIRONMENTAL TEMPERATURE; FLUID RESUSCITATION; GENE MUTATION; GENERAL PRACTITIONER; GENETIC SCREENING; HEAT STROKE; HUMAN; HYPERCAPNIA; HYPOXIA; IN VITRO STUDY; KNEE ARTHROSCOPY; LACTIC ACIDOSIS; MALIGNANT HYPERTHERMIA; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE FUNCTION; MUSCLE NECROSIS; MUSCLE RIGIDITY; MYOGLOBINURIA; OUTPATIENT; PATHOPHYSIOLOGY; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RHABDOMYOLYSIS; SARCOPLASMIC RETICULUM;

GENETIC TESTING; HEAT STROKE; MALIGNANT HYPERTHERMIA; PHARMACOGENETICS; RHABDOMYOLYSIS;

ADULT; DISEASE SUSCEPTIBILITY; HEAT STROKE; HUMANS; MALE; MALIGNANT HYPERTHERMIA; PHYSICAL EXERTION; RHABDOMYOLYSIS; RUNNING;

EID: 84883492649     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12232     Document Type: Article

References (25)

1. Litman R, Rosenberg H. Malignant hyperthermia: update on susceptibility testing. JAMA 2005; 293: 2918-2924.
2. Stowell K. Malignant hyperthermia: a pharmacogenetic disorder. Pharmacogenomics 2008; 9: 1657-1672.
3. Brady J, Sun L, Rosenberg H, Li G. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005. Anesth Analg 2009; 109: 1162-1166.
4. Sumitani M, Uchida K, Yasunaga H, Horiguchi H, Kusakabe Y, Matsuda S etal. Prevalence of malignant hyperthermia and relationship with anesthetics in Japan. Anesthesiology 2011; 114: 84-90.
5. Monnier N, Krivosic-Horber R, Payen JF, Kozak-Ribbens G, Nivoche Y, Adnet P etal. Presence of two different genetic traits in malignant hyperthermia families. Anesthesiology 2002; 97: 1067-1074.
6. European Malignant Hyperthermia Group. Genetics in Malignant Hyperthermia. Leeds: European Malignant Hyperthermia Group; 2011; [cited 2012 Sep 26]. Available from URL: http://www.emhg.org/genetics/
7. Landau M, Kenney K, Deuster P, Campbell W. Exertional rhabdomyolysis: a clinical review with a focus on genetic influences. J Clin Neuromuscul Dis 2012; 13: 122-136.
8. Louis C, Zualkernan K, Roghair T, Mickelson J. The effects of volatile anesthetics on calcium regulation by malignant hyperthermia-susceptible sacroplasmic reticulum. Anesthesiology 1992; 77: 114-125.
9. Ørding H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF etal. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and un-related low-risk subjects. Acta Anaesthesiol Scand 1997; 41: 955-966.
10. Allen G, Larach M, Kunselman A. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. Anesthesiology 1998; 88: 579-588.
11. Capacchione J, Muldoon S. The relationship between exertional heat illness, exertional rhabdomyolysis and malignant hyperthermia. Anesth Analg 2009; 109: 1065-1069.
12. Gronert G, Thompson R, Onofrio B. Human malignant hyperthermia: awake episodes and correction by dantrolene. Anesth Analg 1980; 59: 377-378.
13. Denborough MA. Heat stroke and malignant hyperpyrexia. Med J Aust 1982; 6: 204-205.
14. Poels P, Joosten E, Sengers R, Stadhouders A, Veerkamp J, Benders A. In vitro contraction test for malignant hyperthermia in patients with unexplained recurrent rhabdomyolysis. J Neurol Sci 1991; 105: 67-72.
15. Hackl W, Winkler M, Mauritz W, Sporn P, Steinbereithner K. Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise-induced myolysis. Br J Anaesth 1991; 66: 138-140.
16. Hopkins P, Ellis F, Halsall P. Evidence for related myopathies in exertional heat stroke and malignant hyperthermia. Lancet 1991; 338: 1491-1492.
17. Figarella-Branger D, Kozak-Ribbens G, Rodet L, Aubert M, Borsarelli J, Cozzone P etal. Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromuscul Disord 1993; 3: 553-556.
18. Ogletree J, Antognini J, Gronert G. Postexercise muscle cramping associated with positive malignant hyperthermia contracture testing. Am J Sports Med 1996; 24: 49-51.
19. Kochling A, Wappler F, Winkler G, Schulte am Esch J. Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia. Anaesth Intensive Care 1998; 26: 315-318.
20. Wappler F, Fiege M, Steinfath M, Agarwal K, Scholz J, Singh S etal. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology 2001; 94: 95-100.
21. Tobin J, Jason D, Challa V, Nelson T, Sambuughin N. Malignant hyperthermia and apparent heat stroke. JAMA 2001; 286: 168-169.
22. Davis M, Brown R, Dickson A, Horton H, James D, Laing N etal. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. Br J Anaesth 2002; 88: 508-515.
23. Bendahan D, Kozak-Ribbens G, Confort-Gouny S, Ghattas B, Figarella-Branger D, Aubert M etal. A noninvasive investigation of muscle energetic supports similarities between exertional heat stroke and malignant hyperthermia. Anaesth Analg 2001; 93: 683-689.
24. Campbell I, Ellis F, Evans T, Mortimer M. Studies of body temperature, blood lactate, cortisol and free fatty acid levels during exercise in human subjects susceptible to malignant hyperpyrexia. Acta Anaesthesiol Scand 1983; 27: 349-355.
25. Green J, Ellis F, Halsall P, Campbell I, Currie S, Caddy J. Thermoregulation, plasma catecholamine and metabolite levels during submaximal work in individuals susceptible to malignant hyperpyrexia. Acta Anaesthesiol Scand 1987; 31: 122-126.